Fairfax Financial Holdings’s Pfizer PFE Stock Holding History

Fairfax Financial Holdings’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$27.8M	Buy	990,900 +100,000	+11%	+$2.66M	1.43%	14
2025 Q4	$22.2M	Hold	890,900	–	–	1.06%	17
2025 Q3	$22.7M	Buy	890,900 +240,000	+37%	+$5.92M	1.1%	16
2025 Q2	$15.8M	Hold	650,900	–	–	0.84%	15
2025 Q1	$16.5M	Hold	650,900	–	–	0.89%	15
2024 Q4	$17.3M	Buy	650,900 +190,000	+41%	+$5.15M	1.11%	15
2024 Q3	$13.3M	Hold	460,900	–	–	1.21%	13
2024 Q2	$12.9M	Hold	460,900	–	–	1.09%	15
2024 Q1	$12.8M	Hold	460,900	–	–	1.04%	14
2023 Q4	$13.3M	Hold	460,900	–	–	0.9%	15
2023 Q3	$15.3M	Hold	460,900	–	–	0.82%	15
2023 Q2	$16.9M	Hold	460,900	–	–	0.9%	15
2023 Q1	$18.8M	Hold	460,900	–	–	1.07%	15
2022 Q4	$23.6M	Hold	460,900	–	–	0.59%	16
2022 Q3	$20.2M	Buy	460,900 +60,000	+15%	+$2.92M	0.52%	17
2022 Q2	$21M	Hold	400,900	–	–	0.74%	16
2022 Q1	$20.8M	Hold	400,900	–	–	0.69%	12
2021 Q4	$23.7M	Hold	400,900	–	–	0.76%	10
2021 Q3	$17.2M	Hold	400,900	–	–	0.56%	12
2021 Q2	$15.7M	Hold	400,900	–	–	0.51%	16
2021 Q1	$14.5M	Buy	400,900 +100,000	+33%	+$3.55M	0.51%	18
2020 Q4	$11.1M	Buy	+300,900	New	+$11M	0.49%	17
2018 Q1	–	Sell	-221,340	Closed	-$7.61M	–	46
2017 Q4	$7.61M	Hold	221,340	–	–	0.54%	12
2017 Q3	$7.49M	Hold	221,340	–	–	0.61%	12
2017 Q2	$7.05M	Hold	221,340	–	–	0.62%	13
2017 Q1	$7.18M	Hold	221,340	–	–	0.58%	13
2016 Q4	$6.82M	Hold	221,340	–	–	0.58%	14
2016 Q3	$7.11M	Hold	221,340	–	–	0.64%	11
2016 Q2	$7.39M	Hold	221,340	–	–	0.48%	12
2016 Q1	$6.22M	Hold	221,340	–	–	0.37%	14
2015 Q4	$6.78M	Sell	221,340 -26,350	-11%	-$829K	0.55%	13
2015 Q3	$7.38M	Hold	247,690	–	–	0.68%	11
2015 Q2	$7.88M	Hold	247,690	–	–	0.58%	11
2015 Q1	$8.18M	Hold	247,690	–	–	0.58%	11
2014 Q4	$7.32M	Hold	247,690	–	–	0.47%	11
2014 Q3	$6.95M	Hold	247,690	–	–	0.47%	13
2014 Q2	$6.97M	Hold	247,690	–	–	0.48%	12
2014 Q1	$7.55M	Hold	247,690	–	–	0.53%	11
2013 Q4	$7.2M	Hold	247,690	–	–	0.55%	12
2013 Q3	$6.75M	Hold	247,690	–	–	0.42%	13
2013 Q2	$6.59M	Buy	+247,690	New	+$6.84M	0.27%	18

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Fairfax Financial Holdings's PFE Position: Q1 2026 in Review

Fairfax Financial Holdings increased its Pfizer (PFE) stake by 11% in Q1 2026, buying an estimated $2.66M and bringing the position to 990,900 shares worth $27.8M. The position accounts for 1.43% of the portfolio, ranked #14.

Fairfax Financial Holdings first reported a position in PFE in Q2 2013 and has held it in 41 quarters since. 2,938 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

Fairfax Financial Holdings held 990,900 shares of Pfizer worth $27.8M as of Q1 2026.
Fairfax Financial Holdings bought 100,000 Pfizer shares in Q1 2026, an estimated $2.66M.
Pfizer made up 1.43% of Fairfax Financial Holdings's portfolio in Q1 2026, its #14 holding.
Fairfax Financial Holdings first reported a position in Pfizer in Q2 2013 and has held it in 41 quarters since.
2,938 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Fairfax Financial Holdings's 13F filing for Q1 2026, filed 15 May 2026.